Cargando…
Aldo-Keto Reductase Family 1 Member B10 Inhibitors: Potential Drugs for Cancer Treatment
Cytosolic NADPH-dependent reductase AKR1B10 is a member of the aldo-keto reductase (AKR) superfamily. This enzyme is normally expressed in the gastrointestinal tract. However, it is overexpressed in many solid tumors, such as hepatocarcinoma, lung cancer and breast cancer. AKR1B10 may play a role in...
Autores principales: | Huang, Li, He, Rongzhang, Luo, Weihao, Zhu, Yuan-Shan, Li, Jia, Tan, Tan, Zhang, Xi, Hu, Zheng, Luo, Dixian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403964/ https://www.ncbi.nlm.nih.gov/pubmed/26844556 http://dx.doi.org/10.2174/1574892811888160304113346 |
Ejemplares similares
-
Low expression of Aldo–keto reductase 1B10 is a novel independent prognostic indicator for nasopharyngeal carcinoma
por: Guo, Yuanwei, et al.
Publicado: (2016) -
Aldo-Keto Reductases in the Eye
por: Huang, Shun Ping, et al.
Publicado: (2010) -
Impact of cytotoxic chemotherapy on aldo-keto reductase family 1 member B10 expression
por: Robinson, Kathy, et al.
Publicado: (2023) -
New cancers therapy through targeting Aldo-keto reductase family 1 member B10 with miRNAs
por: He, Rong-Zhang, et al.
Publicado: (2020) -
Expression of Aldo-Keto Reductase Family 1 Member B10 in the Early Stages of Human Hepatocarcinogenesis
por: Tsuzura, Hironori, et al.
Publicado: (2014)